Complex renal cysts associated with crizotinib treatment

Cancer Medicine
Patrick SchnellJi-Youn Han

Abstract

An apparent causal association between crizotinib treatment and renal cyst development emerged during clinical trials in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). Serious adverse event (SAE) reports of renal cysts from a safety database of 1375 patients from four clinical trials were reviewed. A blinded, retrospective, independent radiologic review (IRR) was performed using scans from patients on study for ≥ 6 months in three clinical trials; risk factors for renal cyst development were assessed. Among 17 patients with renal cysts reported as SAEs, evidence of invasion into adjacent structures was noted in seven patients, with no evidence of malignancy found. These patients generally did not require dose reductions, none required permanent crizotinib discontinuation due to this AE, and most continued treatment with clinical benefit. In the blinded IRR, among 255 crizotinib-treated patients, 22%, 3%, and 2% had preexisting simple cysts, complex cysts, or both, respectively. At the 6-month tumor assessment, 9% of all patients had acquired new cysts, and 2% of patients with preexisting cysts had developed new cysts and enlargements (>50%) of preexisting simple cysts. Asians appeared to have an i...Continue Reading

References

Feb 1, 1997·Radiology·A J DavidsonB J Wagner
Jul 31, 2003·Clinical Radiology·Z I Carrim, J T Murchison
Sep 6, 2005·Urology·Gary M Israel, Morton A Bosniak
Dec 7, 2006·Radiologic Clinics of North America·Therese M Weber
Mar 11, 2008·Radiologic Clinics of North America·Srinivasa R PrasadVenkateswar R Surabhi
Sep 9, 2008·Journal of the American Society of Nephrology : JASN·Garabed Eknoyan
Apr 7, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Thomas F Whelan
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Dec 1, 2011·Therapeutic Advances in Medical Oncology·J Rafael Sierra, Ming-Sound Tsao
Oct 19, 2012·Oncology·Nicolas PécuchetStéphane Oudard
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Dec 2, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yen-Ting LinPan-Chyr Yang
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators

❮ Previous
Next ❯

Citations

Mar 10, 2016·Journal of Hematology & Oncology·Jingjing WuDelong Liu
Apr 30, 2015·Targeted Oncology·Anum AbbasKetki Tendulkar
Jul 15, 2015·Insights Into Imaging·Jemianne Bautista JiaScott C Goodwin
Jul 30, 2016·Investigational New Drugs·Hassan IzzedineMark A Perazella
Jan 18, 2017·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Ailbhe C O'NeillNikhil H Ramaiya
Aug 11, 2017·Internal Medicine·Kageaki TaimaSadatomo Tasaka
Aug 2, 2019·Current Opinion in Infectious Diseases·Sibylle C MellinghoffOliver A Cornely
Jul 13, 2016·Advances in Anatomic Pathology·Megan L TroxellNeeraja Kambham
Mar 28, 2020·International Medical Case Reports Journal·Pietro Di MarinoMichele De Tursi
Feb 18, 2017·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Laird B CameronBimal Kumar Parameswaran
Sep 28, 2018·International Journal of Molecular Sciences·Taro YasumaOsamu Hataji
Apr 18, 2021·Cancer Treatment and Research Communications·Ling YangXiaomin Niu
Jul 9, 2021·Kidney Research and Clinical Practice·Min Hee Hong

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
biopsy
biopsies

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.